ArticleJAMIA open2026
Preliminary insights into artificial intelligence guided dosing in hypertension and diabetes: challenges and lessons learnt in a pilot feasibility study.
Jennifer Sumner et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.